Physician profile
Duc T Le
NPI 1295758936
$1,345.03
in general payments reported to CMS, 2019-2025
6 companies · $37.29 in 2025
The $37.29 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $180 · 2021: $406 · 2022: $124 · 2023: $148 · 2024: $272 · 2025: $37.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $892.76 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Boston Scientific Corporation | $131.05 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $123.75 | 2020-2024 | Xarelto |
| Medtronic, INC. | $95.28 | 2021-2024 | Intellis Adaptivestim |
| Cashflow Solutions, LLC | $59.13 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Organogenesis INC. | $43.06 | 2021-2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duc Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.